- Report
- March 2024
- 198 Pages
Global
From €3242EUR$3,374USD£2,772GBP
€3602EUR$3,749USD£3,080GBP
- Report
- January 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- October 2023
- 175 Pages
Global
From €4708EUR$4,900USD£4,025GBP
- Clinical Trials
- April 2024
- 65 Pages
Global
From €1441EUR$1,500USD£1,232GBP
- Report
- October 2023
- 105 Pages
Global
From €2402EUR$2,500USD£2,054GBP
- Report
- January 2024
- 214 Pages
Global
€4799EUR$4,995USD£4,103GBP
- Report
- March 2024
- 196 Pages
Global
From €3242EUR$3,374USD£2,772GBP
€3602EUR$3,749USD£3,080GBP
- Report
- March 2024
- 196 Pages
Global
From €3242EUR$3,374USD£2,772GBP
€3602EUR$3,749USD£3,080GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1441EUR$1,500USD£1,232GBP
- Report
- January 2024
- 141 Pages
Global
From €7206EUR$7,500USD£6,161GBP
- Report
- January 2022
- 60 Pages
Global
From €3795EUR$3,950USD£3,245GBP
- Report
- January 2022
- 60 Pages
Global
From €3795EUR$3,950USD£3,245GBP
- Report
- August 2022
Global
From €759EUR$790USD£649GBP
- Report
- August 2021
Europe
From €3286EUR$3,420USD£2,809GBP
- Report
- August 2021
Global
From €3834EUR$3,990USD£3,278GBP
- Report
- February 2023
- 307 Pages
Global
From €2402EUR$2,500USD£2,054GBP
- Clinical Trials
- June 2020
- 79 Pages
Global
From €2402EUR$2,500USD£2,054GBP
- Clinical Trials
- December 2021
- 283 Pages
Global
From €2402EUR$2,500USD£2,054GBP
- Clinical Trials
- December 2019
- 1881 Pages
Global
From €2402EUR$2,500USD£2,054GBP
- Drug Pipelines
- March 2021
Global
From €1922EUR$2,000USD£1,643GBP
Neuralgia is a type of chronic pain that affects the nerves of the central nervous system. It is often caused by nerve damage or irritation, and can be difficult to treat. Neuralgia drugs are used to reduce the pain associated with this condition. These drugs work by blocking the transmission of pain signals from the affected nerves to the brain. Commonly used neuralgia drugs include anticonvulsants, antidepressants, and opioids. These drugs can be taken orally, injected, or applied topically.
The neuralgia drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in this market include Pfizer, GlaxoSmithKline, Novartis, Merck, and Johnson & Johnson. These companies are constantly developing new drugs and treatments to improve the quality of life for those suffering from neuralgia. Show Less Read more